Variant report
Variant | nsv1000138 |
---|---|
Chromosome Location | chr3:162503110-162546217 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs369772624 | chr3:162503228-162503229 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114360916 | chr3:162503233-162503234 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536484948 | chr3:162503247-162503248 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11926729 | chr3:162503288-162503289 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150214 | chr3:162503292-162503293 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs73167658 | chr3:162503302-162503303 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs115233715 | chr3:162503356-162503357 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150862427 | chr3:162503366-162503367 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558547629 | chr3:162503396-162503397 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532011659 | chr3:162503439-162503440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551519326 | chr3:162503440-162503441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571607803 | chr3:162503445-162503446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4007776 | chr3:162503465-162503466 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs4007775 | chr3:162503475-162503476 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs77966297 | chr3:162503494-162503495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181666909 | chr3:162503503-162503504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs143996314 | chr3:162503523-162503524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376045270 | chr3:162503524-162503525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186238931 | chr3:162503526-162503527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35435212 | chr3:162503535-162503536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73167661 | chr3:162503539-162503540 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs190709341 | chr3:162503572-162503573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577215385 | chr3:162503604-162503605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3866343 | chr3:162503617-162503618 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs79287093 | chr3:162503630-162503631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147315052 | chr3:162503741-162503742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73011773 | chr3:162503744-162503745 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs141040754 | chr3:162503749-162503750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149659835 | chr3:162503757-162503758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145450421 | chr3:162503773-162503774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148412391 | chr3:162503780-162503781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs3866344 | chr3:162503783-162503784 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs370970400 | chr3:162503790-162503791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527647532 | chr3:162503811-162503812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs142557264 | chr3:162503812-162503813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs4289366 | chr3:162503847-162503848 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs541620193 | chr3:162503861-162503862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530186018 | chr3:162503862-162503863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548937337 | chr3:162503896-162503897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569023396 | chr3:162503911-162503912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537795939 | chr3:162503920-162503921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146469699 | chr3:162503922-162503923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140957238 | chr3:162503950-162503951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs206288 | chr3:162503966-162503967 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs553329811 | chr3:162503976-162503977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573437530 | chr3:162503984-162503985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73167664 | chr3:162504010-162504011 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs556529041 | chr3:162504047-162504048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144783853 | chr3:162504071-162504072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs11927727 | chr3:162504090-162504091 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162503200-162503400 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
2 | chr3:162503400-162519400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:162509200-162512000 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
4 | chr3:162509800-162511000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr3:162510000-162511000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr3:162511400-162512000 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
7 | chr3:162511600-162512000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr3:162516600-162517800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr3:162517800-162520400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
10 | chr3:162519400-162520800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr3:162519800-162520800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr3:162520400-162520800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr3:162520400-162520800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr3:162520800-162521800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr3:162522000-162522200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr3:162532800-162533400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr3:162542600-162543000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |